Tatsis Ourania
- SEC CIK
- 0001789815
In the past year, 7 open-market sale filings worth $6.51M and no purchases.
Current role at each company
- VRTX Vertex Pharmaceuticals IncEVP, Chief Reg. & Quality Off.as of Jul 23, 2026
- ODTX Odyssey Therapeutics, Inc.Directoras of May 11, 2026
- VERV Verve Therapeutics, Inc.Directoras of Jul 28, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $6.51M
- 7 filings
- Net
- −$6.51M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Tatsis Ourania as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VRTX Vertex Pharmaceuticals Inc
EVP, Chief Reg. & Quality Off.30 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 (view filing)4:15 PM ET | Jul 2 | 5 days | Tatsis OuraniaEVP, Chief Reg. & Quality Off. | SSale | −1.50K | $524.99 | −$787.5K | −3.2%45.3K after | 10b5-1 |
| Feb 26, 2026 (view filing) | Feb 25 | 1 day | Tatsis OuraniaEVP, Chief Reg. & Quality Off. | SSale | −260 | $486.35 | −$126.5K | −0.6%46.8K after | 10b5-1 |
| Feb 19, 2026 (view filing) | Feb 17-18 | 2 days | Tatsis OuraniaEVP, Chief Reg. & Quality Off. | SSale | −977 | $483.52 | −$472.4K | −2.0%48.6K after | 2 lots10b5-1 |
| Feb 18, 2026 (view filing) | Feb 13 | 5 days | Tatsis OuraniaEVP, Chief Reg. & Quality Off. | SSale | −1.50K | $499.99 | −$750.0K | −3.1%46.1K after | 10b5-1 |
| Feb 12, 2026 (view filing) | Feb 11 | 1 day | Tatsis OuraniaEVP, Chief Reg. & Quality Off. | SSale | −466 | $460.43 | −$214.6K | −0.9%51.4K after | 10b5-1 |
| Jan 9, 2026 (view filing) | Jan 7 | 2 days | Tatsis OuraniaEVP, Chief Reg. & Quality Off. | SSale | −4.50K | $474.99 | −$2.14M | −9.6%42.3K after | 10b5-1 |
| Dec 5, 2025 (view filing) | Dec 3 | 2 days | Tatsis OuraniaEVP, Chief Reg. & Quality Off. | SSale | −4.50K | $449.99 | −$2.02M | −8.8%46.8K after | 10b5-1 |
| Mar 12, 2025 (view filing) | Mar 10 | 2 days | Tatsis OuraniaEVP, Chief Reg. & Quality Off. | SSale | −3.24K | $499.99 | −$1.62M | −6.0%51.2K after | 10b5-1 |
| Mar 6, 2025 (view filing) | Mar 4 | 2 days | Tatsis OuraniaEVP, Chief Reg. & Quality Off. | SSale | −4.06K | $485.49 | −$1.97M | −6.9%54.5K after | 10b5-1 |
| Feb 28, 2025 (view filing) | Feb 27 | 1 day | Tatsis OuraniaEVP, Chief Reg. & Quality Off. | SSale | −530 | $475.34 | −$251.9K | −0.9%58.5K after | 10b5-1 |